{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:26:59Z","timestamp":1787887619960,"version":"build-2784847793"},"reference-count":222,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>In recent times, advances in the field of metabolomics have shed greater light on the role of metabolic disturbances in neuropsychiatric conditions. The following review explores the role of ketone bodies and ketosis in both the diagnosis and treatment of three major psychiatric disorders: major depressive disorder, anxiety disorders, and schizophrenia. Distinction is made between the potential therapeutic effects of the ketogenic diet and exogenous ketone preparations, as exogenous ketones in particular offer a standardized, reproducible manner for inducing ketosis. Compelling associations between symptoms of mental distress and dysregulation in central nervous system ketone metabolism have been demonstrated in preclinical studies with putative neuroprotective effects of ketone bodies being elucidated, including effects on inflammasomes and the promotion of neurogenesis in the central nervous system. Despite emerging pre-clinical data, clinical research on ketone body effectiveness as a treatment option for psychiatric disorders remains lacking. This gap in understanding warrants further investigating, especially considering that safe and acceptable ways of inducing ketosis are readily available.<\/jats:p>","DOI":"10.3389\/fpsyt.2023.1142682","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:00:16Z","timestamp":1681707616000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders"],"prefix":"10.3389","volume":"14","author":[{"given":"Naomi Elyse","family":"Omori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mantas Kazimieras","family":"Malys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latt","family":"Mansor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e19590","DOI":"10.1371\/journal.pone.0019590","article-title":"Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London","volume":"6","author":"Chang","year":"2011","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1192\/bjp.bp.110.085100","article-title":"Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders","volume":"199","author":"Wahlbeck","year":"2011","journal-title":"Br J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.12688\/f1000research.10233.1","article-title":"New drugs in psychiatry: focus on new pharmacological targets","volume":"6","author":"Caraci","year":"2017","journal-title":"F1000Res"},{"key":"ref4","first-page":"17","article-title":"Prevalence and management of treatment-resistant depression","volume":"68","author":"Nemeroff","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1517\/14656566.9.9.1451","article-title":"Antipsychotic-induced extrapyramidal symptoms and their management","volume":"9","author":"Dayalu","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"ref6","first-page":"148","article-title":"Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports","volume":"22","author":"Madhusoodanan","year":"2010","journal-title":"Ann Clin Psychiatry"},{"key":"ref7","first-page":"48","article-title":"The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports","volume":"9","author":"Evans","year":"2007","journal-title":"MedGenMed"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1345\/aph.1G293","article-title":"Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults","volume":"40","author":"Jacob","year":"2006","journal-title":"Ann Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e94112","DOI":"10.1371\/journal.pone.0094112","article-title":"Almost all antipsychotics result in weight gain: a meta-analysis","volume":"9","author":"Bak","year":"2014","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"17r02185","DOI":"10.4088\/PCC.17r02185","article-title":"Neuroleptic malignant syndrome: diagnosis and management","volume":"20","author":"Ware","year":"2018","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.1993.03500200087039","article-title":"The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered","volume":"269","author":"Glassman","year":"1993","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjp.bp.112.117002","article-title":"Genome-wide association studies in psychiatry: what have we learned?","volume":"202","author":"Collins","year":"2013","journal-title":"Br J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41398-019-0570-y","article-title":"Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses","volume":"9","author":"Yuan","year":"2019","journal-title":"Transl Psychiatry"},{"key":"ref14","first-page":"8","article-title":"La lutte contre l'epiepsie par la desintoxication et par la reeducation alimentaire","volume":"78","author":"Guelpa","year":"1911","journal-title":"Rev Ther Med Chir"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.pnpbp.2010.07.030","article-title":"Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders","volume":"35","author":"Gardner","year":"2011","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pnpbp.2018.09.004","article-title":"Link between depression and cardiovascular diseases due to epigenomics and proteomics: focus on energy metabolism","volume":"89","author":"Kahl","year":"2019","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-16183-x","article-title":"Ketamine\u2019s antidepressant effect is mediated by energy metabolism and antioxidant defense system","volume":"7","author":"Weckmann","year":"2017","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"846183","DOI":"10.3389\/fnhum.2022.846183","article-title":"Exogenous ketones and lactate as a potential therapeutic intervention for brain injury and neurodegenerative conditions","volume":"16","author":"Omori","year":"2022","journal-title":"Front Hum Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"Beta-hydroxybutyrate: a signaling metabolite","volume":"37","author":"Newman","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"key":"ref22","volume-title":"Ketoacidosis","author":"Ghimire","year":"2022"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi","year":"2009","journal-title":"Diabetes Care"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/osp4.516","article-title":"Measuring ketone bodies for the monitoring of pathologic and therapeutic ketosis","volume":"7","author":"Anderson","year":"2021","journal-title":"Obes Sci Pract"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.redox.2018.01.013","article-title":"Fasting exacerbates hepatic growth differentiation factor 15 to promote fatty acid \u03b2-oxidation and ketogenesis via activating XBP1 signaling in liver","volume":"16","author":"Zhang","year":"2018","journal-title":"Redox Biol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cmet.2016.07.010","article-title":"Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes","volume":"24","author":"Cox","year":"2016","journal-title":"Cell Metab"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3389\/fphys.2017.00848","article-title":"On the Metabolism of Exogenous Ketones in Humans","volume":"8","author":"Stubbs","year":"2017","journal-title":"Front Physiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1113\/JP273185","article-title":"Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation","volume":"595","author":"Evans","year":"2017","journal-title":"J Physiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuint.2017.05.019","article-title":"Neuroketotherapeutics: A modern review of a century-old therapy","volume":"117","author":"Koppel","year":"2018","journal-title":"Neurochem Int"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"101269","DOI":"10.1016\/j.molmet.2021.101269","article-title":"Diminished ketone interconversion, hepatic TCA cycle flux, and glucose production in D-\u03b2-hydroxybutyrate dehydrogenase hepatocyte-deficient mice","volume":"53","author":"Stagg","year":"2021","journal-title":"Mol Metab"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ejcn.2013.116","article-title":"Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets","volume":"67","author":"Paoli","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.yebeh.2013.09.032","article-title":"A decade of the modified Atkins diet (2003-2013): results, insights, and future directions","volume":"29","author":"Kossoff","year":"2013","journal-title":"Epilepsy Behav"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jamainternmed.2019.2633","article-title":"The ketogenic diet for obesity and diabetes-enthusiasm outpaces evidence","volume":"179","author":"Joshi","year":"2019","journal-title":"JAMA Intern Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12970-020-00362-9","article-title":"A review of the ketogenic diet for endurance athletes: performance enhancer or placebo effect?","volume":"17","author":"Bailey","year":"2020","journal-title":"J Int Soc Sports Nutr"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/OAJSM.S180409","article-title":"Impact of ketogenic diet on athletes: current insights","volume":"10","author":"McSwiney","year":"2019","journal-title":"Open Access J Sports Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1001\/jama.1925.02660520007003","article-title":"The ketogenic diet in epilepsy","volume":"84","author":"Peterman","year":"1925","journal-title":"J Am Med Assoc"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/nu11102510","article-title":"Ketogenic diet and epilepsy","volume":"11","author":"U\u0142amek-Kozio\u0142","year":"2019","journal-title":"Nutrients"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"104614","DOI":"10.1016\/j.neuint.2019.104614","article-title":"Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases","volume":"133","author":"Camberos-Luna","year":"2020","journal-title":"Neurochem Int"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2008.01821.x","article-title":"History of the ketogenic diet","volume":"49","author":"Wheless","year":"2008","journal-title":"Epilepsia"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jnr.20633","article-title":"Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury","volume":"82","author":"Prins","year":"2005","journal-title":"J Neurosci Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e75713","DOI":"10.1371\/journal.pone.0075713","article-title":"Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer's pathology","volume":"8","author":"Brownlow","year":"2013","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/088307380001501203","article-title":"The ketogenic diet: seizure control correlates better with serum \u03b2-hydroxybutyrate than with urine ketones","volume":"15","author":"Gilbert","year":"2000","journal-title":"J Child Neurol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.seizure.2009.10.009","article-title":"Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine","volume":"19","author":"van Delft","year":"2010","journal-title":"Seizure"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/YCO.0000000000000499","article-title":"Dysregulation of the gut\u2013brain axis in schizophrenia and bipolar disorder: probiotic supplementation as a supportive treatment in psychiatric disorders","volume":"32","author":"Genedi","year":"2019","journal-title":"Curr Opin Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s13668-020-00313-5","article-title":"Probiotics and the microbiota-gut-brain axis: focus on psychiatry","volume":"9","author":"Morkl","year":"2020","journal-title":"Curr Nutr Rep"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3920\/BM2020.0063","article-title":"From probiotics to psychobiotics\u2013the gut-brain axis in psychiatric disorders","volume":"11","author":"Zag\u00f3rska","year":"2020","journal-title":"Benefic Microbes"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11154-019-09518-8","article-title":"Keto microbiota: a powerful contributor to host disease recovery","volume":"20","author":"Cabrera-Mulero","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"vi78","DOI":"10.1093\/neuonc\/nox168.322","article-title":"EXTH-30. Therapeutic benefit of a ketogenic diet through altered gut microbiota in a mouse model of Glioma","volume":"19","author":"McFarland","year":"2017","journal-title":"Neuro-Oncology"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.3748\/wjg.v23.i33.6164","article-title":"Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy","volume":"23","author":"Xie","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref50","first-page":"771","article-title":"Studies in epilepsy: VIII. The clinical effect of fasting","volume-title":"Archives of Neurology & Psychiatry 20","author":"Lennox","year":"1928"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1172\/JCI105481","article-title":"Hormone-fuel interrelationships during fasting","volume":"45","author":"Cahill","year":"1966","journal-title":"J Clin Invest"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1172\/JCI105650","article-title":"Brain metabolism during fasting","volume":"46","author":"Owen","year":"1967","journal-title":"J Clin Invest"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.me.24.020173.001415","article-title":"Metabolism of ketone bodies by the brain","volume":"24","author":"Sokoloff","year":"1973","journal-title":"Annu Rev Med"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1528-1157.1974.tb04943.x","article-title":"An animal model for the ketogenic diet","volume":"15","author":"Appleton","year":"1974","journal-title":"Epilepsia"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1073\/pnas.1035720100","article-title":"Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake","volume":"100","author":"Anson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","article-title":"Fasting: molecular mechanisms and clinical applications","volume":"19","author":"Longo","year":"2014","journal-title":"Cell Metab"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e0132089","DOI":"10.1371\/journal.pone.0132089","article-title":"Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich\u2019s Ascites Tumor in Mice","volume":"10","author":"Singh","year":"2015","journal-title":"PLoS One"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1210\/en.2015-1622","article-title":"Intermittent Fasting Promotes Fat Loss With Lean Mass Retention, Increased Hypothalamic Norepinephrine Content, and Increased Neuropeptide Y Gene Expression in Diet-Induced Obese Male Mice","volume":"157","author":"Gotthardt","year":"2016","journal-title":"Endocrinology"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.clnu.2020.08.032","article-title":"Exploring the metabolic fate of medium-chain triglycerides in healthy individuals using a stable isotope tracer","volume":"40","author":"Knottnerus","year":"2021","journal-title":"Clin Nutr"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1038\/ncomms8320","article-title":"Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites","volume":"6","author":"Thorburn","year":"2015","journal-title":"Nat Commun"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12986-016-0069-y","article-title":"Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats","volume":"13","author":"Kesl","year":"2016","journal-title":"Nutr Metab (Lond)"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.yrtph.2012.04.001","article-title":"Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate","volume":"63","author":"Clarke","year":"2012","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0899-9007(96)00409-1","article-title":"Potential of ketone body esters for parenteral and oral nutrition","volume":"13","author":"Brunengraber","year":"1997","journal-title":"Nutrition"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.3390\/nu13062066","article-title":"Tolerability and safety of a novel ketogenic ester, bis-hexanoyl (R)-1,3-butanediol: a randomized controlled trial in healthy adults","volume":"13","author":"Chen","year":"2021","journal-title":"Nutrients"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0955-2863(94)00011-A","article-title":"R, S-1, 3-butanediol acetoacetate esters, potential alternates to lipid emulsions for total parenteral nutrition","volume":"6","author":"Desrochers","year":"1995","journal-title":"J Nutr Biochem"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1096\/fj.11-200410","article-title":"Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet","volume":"26","author":"Srivastava","year":"2012","journal-title":"FASEB J"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1249\/JSR.0000000000000732","article-title":"Nutritional ketosis with ketogenic diets or exogenous ketones: features, convergence, and divergence","volume":"19","author":"Poff","year":"2020","journal-title":"Curr Sports Med Rep"},{"key":"ref68","first-page":"1","article-title":"Acute ketone supplementation and exercise performance: a systematic review and meta-analysis of randomized controlled trials","volume-title":"Int J Sports Physiol Perform","author":"Valenzuela","year":"2020"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1528-1167.2008.01855.x","article-title":"Neuroprotective effects of the ketogenic diet","volume":"49","author":"Noh","year":"2008","journal-title":"Epilepsia"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fnins.2019.01041","article-title":"Ketone administration for seizure disorders: history and rationale for ketone esters and metabolic alternatives","volume":"13","author":"Poff","year":"2019","journal-title":"Front Neurosci"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/dmr.5610050304","article-title":"Ketone body production and disposal: effects of fasting, diabetes, and exercise","volume":"5","author":"Balasse","year":"1989","journal-title":"Diabetes Metab Rev"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"E1161","DOI":"10.1152\/ajpendo.1995.268.6.E1161","article-title":"Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans","volume":"268","author":"Hasselbalch","year":"1995","journal-title":"Am J Physiol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/jc.2014-2608","article-title":"Systemic, cerebral and skeletal muscle ketone body and energy metabolism during acute hyper-D-\u03b2-hydroxybutyratemia in post-absorptive healthy males","volume":"100","author":"Mikkelsen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"E796","DOI":"10.1152\/ajpendo.90644.2008","article-title":"PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis","volume":"296","author":"Bentourkia","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1179\/1476830510Y.0000000001","article-title":"Mild experimental ketosis increases brain uptake of 11C-acetoacetate and 18F-fluorodeoxyglucose: a dual-tracer PET imaging study in rats","volume":"14","author":"Pifferi","year":"2011","journal-title":"Nutr Neurosci"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1203\/00006450-200208000-00025","article-title":"Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy","volume":"52","author":"Plecko","year":"2002","journal-title":"Pediatr Res"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.plefa.2003.07.006","article-title":"Brain uptake and metabolism of ketone bodies in animal models","volume":"70","author":"Nehlig","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/bj1220013","article-title":"Ketone-body utilization by adult and suckling rat brain in vivo","volume":"122","author":"Hawkins","year":"1971","journal-title":"Biochem J"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"6902","DOI":"10.1074\/jbc.M110.192369","article-title":"Obligate role for ketone body oxidation in neonatal metabolic homeostasis","volume":"286","author":"Cotter","year":"2011","journal-title":"J Biol Chem"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00390-6","article-title":"Addressing the burden of mental, neurological, and substance use disorders: key messages from disease control priorities","volume":"387","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1741-7015-9-90","article-title":"Cross-national epidemiology of DSM-IV major depressive episode","volume":"9","author":"Bromet","year":"2011","journal-title":"BMC Med"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1176\/appi.ajp.2013.13030325","article-title":"Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses","volume":"171","author":"Cuijpers","year":"2014","journal-title":"Am J Psychiatry"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","article-title":"Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis","volume":"72","author":"Walker","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.neuron.2014.01.027","article-title":"The genetics of major depression","volume":"81","author":"Flint","year":"2014","journal-title":"Neuron"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.expneurol.2011.10.032","article-title":"Current research trends in early life stress and depression: review of human studies on sensitive periods, gene\u2013environment interactions, and epigenetics","volume":"233","author":"Heim","year":"2012","journal-title":"Exp Neurol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1017\/S0033291715002743","article-title":"Maltreatment in childhood substantially increases the risk of adult depression and anxiety in prospective cohort studies: systematic review, meta-analysis, and proportional attributable fractions","volume":"46","author":"Li","year":"2016","journal-title":"Psychol Med"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/mp.2015.50","article-title":"The association between lower educational attainment and depression owing to shared genetic effects? Results in~ 25 000 subjects","volume":"20","author":"Peyrot","year":"2015","journal-title":"Mol Psychiatry"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/aje\/kwf182","article-title":"Socioeconomic inequalities in depression: a meta-analysis","volume":"157","author":"Lorant","year":"2003","journal-title":"Am J Epidemiol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1001\/jama.2009.878","article-title":"Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis","volume":"301","author":"Risch","year":"2009","journal-title":"JAMA"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.physbeh.2016.11.014","article-title":"A users guide to HPA axis research","volume":"178","author":"Spencer","year":"2017","journal-title":"Physiol Behav"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.psyneuen.2010.04.001","article-title":"Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis","volume":"35","author":"Knorr","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/PSY.0b013e31820ad12b","article-title":"Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research","volume":"73","author":"Stetler","year":"2011","journal-title":"Psychosom Med"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/archpsyc.61.12.1235","article-title":"Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial","volume":"61","author":"Jahn","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2215-0366(15)00436-8","article-title":"Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial","volume":"3","author":"McAllister-Williams","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpsychires.2009.07.012","article-title":"The impact of treatment on HPA axis activity in unipolar major depression","volume":"44","author":"McKay","year":"2010","journal-title":"J Psychiatr Res"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1126\/science.6334362","article-title":"Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients","volume":"226","author":"Nemeroff","year":"1984","journal-title":"Science"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav Immun"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/mp.2015.57","article-title":"Gene expression in major depressive disorder","volume":"21","author":"Jansen","year":"2016","journal-title":"Mol Psychiatry"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11011-008-9114-5","article-title":"Neuropsychiatric disorders related to interferon and interleukins treatment","volume":"24","author":"Myint","year":"2009","journal-title":"Metab Brain Dis"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","article-title":"Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes","volume":"72","author":"Setiawan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","article-title":"Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide","volume":"42","author":"Steiner","year":"2008","journal-title":"J Psychiatr Res"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamapsychiatry.2014.2206","article-title":"Identification of a common neurobiological substrate for mental illness","volume":"72","author":"Goodkind","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"e3769","DOI":"10.3791\/3769","article-title":"The tail suspension test","author":"Can","year":"2012","journal-title":"J Vis Exp"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/00004647-200207000-00014","article-title":"[2,4-13 C2]-beta-Hydroxybutyrate metabolism in human brain","volume":"22","author":"Pan","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.09.040","article-title":"Glutamine has antidepressive effects through increments of glutamate and glutamine levels and glutamatergic activity in the medial prefrontal cortex","volume":"143","author":"Son","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/diagnostics12040813","article-title":"The plasma levels of 3-hydroxybutyrate, dityrosine, and other markers of oxidative stress and energy metabolism in major depressive disorder","volume":"12","author":"Krivosova","year":"2022","journal-title":"Diagnostics"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"112219","DOI":"10.1016\/j.jep.2019.112219","article-title":"Plasma metabolomics of depressed patients and treatment with Xiaoyaosan based on mass spectrometry technique","volume":"246","author":"Liu","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"e0165267","DOI":"10.1371\/journal.pone.0165267","article-title":"Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis","volume":"11","author":"Setoyama","year":"2016","journal-title":"PLoS One"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/npr2.12164","article-title":"Stress increases blood beta-hydroxybutyrate levels and prefrontal cortex NLRP3 activity jointly in a rodent model","volume":"41","author":"Nishiguchi","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.psyneuen.2014.03.008","article-title":"Rise of ketone bodies with psychosocial stress in normal weight men","volume":"45","author":"Kubera","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2147\/IJGM.S300517","article-title":"Serum 3-Hydroxybutyrate in patients with psychogenic somatoform symptoms may be a predictor of the effectiveness of sertraline and venlafaxine","volume":"14","author":"Saito","year":"2021","journal-title":"Int J General Med"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bjorkholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.mad.2011.09.005","article-title":"Short bouts of mild-intensity physical exercise improve spatial learning and memory in aging rats: involvement of hippocampal plasticity via AKT, CREB and BDNF signaling","volume":"132","author":"Aguiar","year":"2011","journal-title":"Mech Ageing Dev"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2007.06.011","article-title":"Exercise builds brain health: key roles of growth factor cascades and inflammation","volume":"30","author":"Cotman","year":"2007","journal-title":"Trends Neurosci"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s11011-009-9157-2","article-title":"Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats","volume":"24","author":"Marais","year":"2009","journal-title":"Metab Brain Dis"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety","volume":"10","author":"Martinowich","year":"2007","journal-title":"Nat Neurosci"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0306-4522(00)00349-3","article-title":"Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus","volume":"101","author":"Russo-Neustadt","year":"2000","journal-title":"Neuroscience"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2147\/NDT.S58455","article-title":"Improvement of gross motor and cognitive abilities by an exercise training program: three case reports","volume":"10","author":"Alesi","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsams.2013.02.007","article-title":"Effects of acute resistance exercise on cognition in late middle-aged adults: general or specific cognitive improvement?","volume":"17","author":"Chang","year":"2014","journal-title":"J Sci Med Sport"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9234105","article-title":"Exercise intervention associated with cognitive improvement in Alzheimer\u2019s disease","volume":"2018","author":"Cui","year":"2018","journal-title":"Neural Plast"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.psychsport.2009.09.006","article-title":"The effect of acute physical exercise on cognitive function during development","volume":"11","author":"Ellemberg","year":"2010","journal-title":"Psychol Sport Exerc"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"e15092","DOI":"10.7554\/eLife.15092","article-title":"Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body \u03b2-hydroxybutyrate","volume":"5","author":"Sleiman","year":"2016","journal-title":"elife"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.biopsych.2004.09.019","article-title":"The antidepressant properties of the ketogenic diet","volume":"56","author":"Murphy","year":"2004","journal-title":"Biol Psychiatry"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbi.2020.05.032","article-title":"Anti-depression effects of ketogenic diet are mediated via the restoration of microglial activation and neuronal excitability in the lateral habenula","volume":"88","author":"Guan","year":"2020","journal-title":"Brain Behav Immun"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.dsx.2019.01.055","article-title":"Ketogenic diets potentially reverse type II diabetes and ameliorate clinical depression: a case study","volume":"13","author":"Cox","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/ncomms4944","article-title":"The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages","volume":"5","author":"Rahman","year":"2014","journal-title":"Nat Commun"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fncel.2015.00521","article-title":"Depression as a glial-based synaptic dysfunction","volume":"9","author":"Rial","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbrc.2017.05.184","article-title":"Beta-hydroxybutyrate alleviates depressive behaviors in mice possibly by increasing the histone3-lysine9-beta-hydroxybutyrylation","volume":"490","author":"Chen","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1038\/s41598-017-08055-1","article-title":"Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses","volume":"7","author":"Yamanashi","year":"2017","journal-title":"Sci Rep"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/npr2.12099","article-title":"Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression","volume":"40","author":"Kajitani","year":"2020","journal-title":"Neuropsychopharmacol Rep"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/npr2.12226","article-title":"Acute and chronic effects of oral administration of a medium-chain fatty acid, capric acid, on locomotor activity and anxiety-like and depression-related behaviors in adult male C57BL\/6J mice","volume":"42","author":"Shoji","year":"2022","journal-title":"Neuropsychopharmacol Rep"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2022","journal-title":"Dialogues Clin Neurosci"},{"key":"ref135","first-page":"133","article-title":"The role of GABA in the pathophysiology and treatment of anxiety disorders","volume":"37","author":"Nemeroff","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress Anxiety"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.biopsych.2011.06.009","article-title":"Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways","volume":"70","author":"Filiou","year":"2011","journal-title":"Biol Psychiatry"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"M111.008110","DOI":"10.1074\/mcp.M111.008110","article-title":"Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut\u2013brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/acps.13310","article-title":"Metabolomic profiles discriminating anxiety from depression","volume":"144","author":"de Kluiver","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"136443","DOI":"10.1016\/j.neulet.2021.136443","article-title":"A combination of ketogenic diet and voluntary exercise ameliorates anxiety and depression-like behaviors in Balb\/c mice","volume":"770","author":"Gumus","year":"2022","journal-title":"Neurosci Lett"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuropharm.2018.06.017","article-title":"Medium chain triglyceride diet reduces anxiety-like behaviors and enhances social competitiveness in rats","volume":"138","author":"Hollis","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"e00300","DOI":"10.1002\/brb3.300","article-title":"Gestational ketogenic diet programs brain structure and susceptibility to depression & anxiety in the adult mouse offspring","volume":"5","author":"Sussman","year":"2015","journal-title":"Brain Behav"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"e23684","DOI":"10.7759\/cureus.23684","article-title":"Effects of a ketogenic diet on symptoms, biomarkers, depression, and anxiety in Parkinson\u2019s disease: a case study","volume":"14","author":"Tidman","year":"2022","journal-title":"Cureus"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/nmt-2021-0033","article-title":"Effects of an low carbohydrate\/healthy fat\/ketogenic diet on biomarkers of health and symptoms, anxiety and depression in Parkinson's disease: a pilot study","volume":"12","author":"Tidman","year":"2022","journal-title":"Neuro Dis Manag"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson's disease: a pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov Disord"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"e58396","DOI":"10.3791\/58396","article-title":"Elevated plus maze test combined with video tracking software to investigate the anxiolytic effect of exogenous ketogenic supplements","author":"Ari","year":"2019","journal-title":"J Vis Exp"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fnmol.2016.00137","article-title":"Exogenous ketone supplements reduce anxiety-related behavior in Sprague-Dawley and Wistar Albino Glaxo\/Rijswijk rats","volume":"9","author":"Ari","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fnbeh.2018.00029","article-title":"Anxiolytic effect of exogenous ketone supplementation is abolished by adenosine A1 receptor inhibition in Wistar albino Glaxo\/Rijswijk rats","volume":"12","author":"Kov\u00e1cs","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fnmol.2017.00235","article-title":"Adenosine A1 receptor antagonism abolished the anti-seizure effects of exogenous ketone supplementation in Wistar albino Glaxo Rijswijk rats","volume":"10","author":"Kovacs","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"21629","DOI":"10.1038\/s41598-020-78410-2","article-title":"Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model","volume":"10","author":"Yamanashi","year":"2020","journal-title":"Sci Rep"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/schbul\/sbi052","article-title":"Variations in the incidence of schizophrenia: data versus dogma","volume":"32","author":"McGrath","year":"2006","journal-title":"Schizophr Bull"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.mppsy.2008.07.011","article-title":"Schizophrenia: epidemiology and risk factors","volume":"7","author":"Oliver","year":"2008","journal-title":"Psychiatry"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1017\/S0033291700011910","article-title":"Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO collaborative study on determinants of outcome of severe mental disorders","volume":"16","author":"Sartorius","year":"1986","journal-title":"Psychol Med"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1359786810385490","article-title":"Suicide and schizophrenia: a systematic review of rates and risk factors","volume":"24","author":"Hor","year":"2010","journal-title":"J Psychopharmacol"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","article-title":"Excess early mortality in schizophrenia","volume":"10","author":"Laursen","year":"2014","journal-title":"Annu Rev Clin Psychol"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/schbul\/sbl071","article-title":"Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis","volume":"33","author":"Eack","year":"2007","journal-title":"Schizophr Bull"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"764","DOI":"10.4088\/JCP.15m10278","article-title":"The economic burden of schizophrenia in the United States in 2013","volume":"77","author":"Cloutier","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/NDT.S225643","article-title":"Negative symptoms in schizophrenia: a review and clinical guide for recognition, assessment, and treatment","volume":"16","author":"Correll","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.psc.2016.01.006","article-title":"Treatment-resistant schizophrenia. Psychiatric","volume":"39","author":"Elkis","year":"2016","journal-title":"Clinics"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","article-title":"Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain","volume":"20","author":"Carlsson","year":"1963","journal-title":"Acta Pharmacol Toxicol"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am J Psychiatry"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbi.2022.01.018","article-title":"Inflammasome activation in psychosis\u2013consequence of peripheral dyslipidaemia or reflection of an inflammatory pathogenesis?","volume":"101","author":"Humble","year":"2022","journal-title":"Brain Behav Immun"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3390\/molecules23082087","article-title":"Current concepts and treatments of schizophrenia","volume":"23","author":"St\u0119pnicki","year":"2018","journal-title":"Molecules"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/s41380-022-01494-x","article-title":"Schizophrenia: a disorder of broken brain bioenergetics","volume":"27","author":"Henkel","year":"2022","journal-title":"Mol Psychiatry"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41398-018-0304-6","article-title":"Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia","volume":"8","author":"Hackinger","year":"2018","journal-title":"Transl Psychiatry"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.molmet.2013.11.007","article-title":"Hypothalamic glucagon signals through the KATP channels to regulate glucose production","volume":"3","author":"Abraham","year":"2014","journal-title":"Mol Metabolism"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"107633","DOI":"10.1016\/j.neuropharm.2019.05.010","article-title":"Brain insulin action in schizophrenia: something borrowed and something new","volume":"163","author":"Agarwal","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41380-018-0045-1","article-title":"Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis","volume":"24","author":"Chouinard","year":"2019","journal-title":"Mol Psychiatry"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2337\/db14-0685","article-title":"Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations","volume":"64","author":"Dash","year":"2015","journal-title":"Diabetes"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/nm1202-798","article-title":"Hypothalamic insulin signaling is required for inhibition of glucose production","volume":"8","author":"Obici","year":"2002","journal-title":"Nat Med"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nature03439","article-title":"Hypothalamic KATP channels control hepatic glucose production","volume":"434","author":"Pocai","year":"2005","journal-title":"Nature"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Lett"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.mehy.2005.06.022","article-title":"Impaired neuronal glucose uptake in pathogenesis of schizophrenia\u2013Can GLUT 1 and GLUT 3 deficits explain imaging, post-mortem and pharmacological findings?","volume":"65","author":"McDermott","year":"2005","journal-title":"Med Hypotheses"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpsychires.2011.09.018","article-title":"Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: implications for brain energy metabolism and neurotrophic signaling","volume":"46","author":"Regenold","year":"2012","journal-title":"J Psychiatr Res"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"e967","DOI":"10.1038\/tp.2016.239","article-title":"Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study","volume":"6","author":"Rowland","year":"2016","journal-title":"Transl Psychiatry"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2014.01.028","article-title":"Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia","volume":"154","author":"Shan","year":"2014","journal-title":"Schizophr Res"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/mp.2011.131","article-title":"Potential metabolite markers of schizophrenia","volume":"18","author":"Yang","year":"2013","journal-title":"Mol Psychiatry"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamapsychiatry.2013.2287","article-title":"In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy","volume":"71","author":"Du","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pscychresns.2008.06.002","article-title":"Creatine abnormalities in schizophrenia and bipolar disorder","volume":"172","author":"Ongur","year":"2009","journal-title":"Psychiatry Res"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"16621","DOI":"10.1073\/pnas.0706778104","article-title":"Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence","volume":"104","author":"Gysin","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.schres.2009.12.017","article-title":"Genetic analysis of glutamate cysteine ligase modifier (GCLM) gene and schizophrenia in Han Chinese","volume":"119","author":"Ma","year":"2010","journal-title":"Schizophr Res"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1086\/507566","article-title":"Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene","volume":"79","author":"Tosic","year":"2006","journal-title":"Am J Hum Genet"},{"key":"ref185","first-page":"18","article-title":"Weight gain with atypical antipsychotics: evidence and insights","volume":"68","author":"Henderson","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","article-title":"Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis","volume":"62","author":"Henderson","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"789","DOI":"10.4088\/JCP.v67n0513","article-title":"Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis","volume":"67","author":"Henderson","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.00164.2018","article-title":"Antipsychotics and glucose metabolism: how brain and body collide","volume":"316","author":"Kowalchuk","year":"2019","journal-title":"Am J Physiol Endo Meta"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.psyneuen.2019.01.029","article-title":"Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons","volume":"104","author":"Kowalchuk","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"CD008016","DOI":"10.1002\/14651858.CD008016.pub3","article-title":"Maintenance treatment with antipsychotic drugs for schizophrenia","volume":"8","author":"Leucht","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.lfs.2018.12.015","article-title":"The IRS\/PI3K\/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats","volume":"217","author":"Ren","year":"2019","journal-title":"Life Sci"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jpsychires.2012.10.005","article-title":"The dietary pattern of patients with schizophrenia: a systematic review","volume":"47","author":"Dipasquale","year":"2013","journal-title":"J Psychiatr Res"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/pcn.13194","article-title":"Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: a targeted metabolomics study","volume":"75","author":"Liu","year":"2021","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"950602","DOI":"10.3389\/fpsyt.2022.950602","article-title":"Plasma metabolomics of schizophrenia with cognitive impairment: a pilot study","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Psychol"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.aca.2020.09.054","article-title":"Metabolomics strategy assisted by transcriptomics analysis to identify biomarkers associated with schizophrenia","volume":"1140","author":"Liu","year":"2020","journal-title":"Anal Chim Acta"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/metabo12080707","article-title":"NMR metabolomics in serum fingerprinting of schizophrenia patients in a Serbian cohort","volume":"12","author":"Simic","year":"2022","journal-title":"Metabolites"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1177\/02698811211035391","article-title":"Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: a systematic review and network meta-analysis","volume":"35","author":"Wang","year":"2021","journal-title":"J Psychopharmacol"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2147\/NDT.S157055","article-title":"Serum levels of beta-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study","volume":"14","author":"Huang","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2016.07.209","article-title":"Beta-hydroxybutyrate, pyruvate and metabolic profiles in patients with schizophrenia: a case control study","volume":"73","author":"Huang","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1440-1819.2010.02094.x","article-title":"Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models","volume":"64","author":"Watanabe","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1017\/neu.2020.27","article-title":"Involvement of NLRP3 inflammasome in schizophrenia-like behaviour in young animals after maternal immune activation","volume":"32","author":"Ventura","year":"2020","journal-title":"Acta Neuropsychiatr"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.it.2015.05.001","article-title":"The Nlrp3 inflammasome admits defeat","volume":"36","author":"Gross","year":"2015","journal-title":"Trends Immunol"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jphysparis.2013.04.003","article-title":"The effect of non-competitive NMDA receptor antagonist MK-801 on neuronal activity in rodent prefrontal cortex: an animal model for cognitive symptoms of schizophrenia","volume":"107","author":"Blot","year":"2013","journal-title":"J Physiol Paris"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.schres.2015.10.041","article-title":"Ketogenic diet reverses behavioral abnormalities in an acute NMDA receptor hypofunction model of schizophrenia","volume":"169","author":"Kraeuter","year":"2015","journal-title":"Schizophr Res"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.schres.2018.11.011","article-title":"Ketogenic diet prevents impaired prepulse inhibition of startle in an acute NMDA receptor hypofunction model of schizophrenia","volume":"206","author":"Kraeuter","year":"2019","journal-title":"Schizophr Res"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.biopsych.2008.04.019","article-title":"Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia","volume":"64","author":"Quednow","year":"2008","journal-title":"Biol Psychiatry"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrn.2017.156","article-title":"Intermittent metabolic switching, neuroplasticity and brain health","volume":"19","author":"Mattson","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.schres.2019.08.002","article-title":"Ketogenic diet and olanzapine treatment alone and in combination reduce a pharmacologically-induced prepulse inhibition deficit in female mice","volume":"212","author":"Kraeuter","year":"2019","journal-title":"Schizophr Res"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1176\/ajp.121.11.1110","article-title":"A pilot study of the ketogenic diet in schizophrenia","volume":"121","author":"Pacheco","year":"1965","journal-title":"Am J Psychiatr"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-0447.1966.tb01920.x","article-title":"Cereals and schizophrenia data and hypothesis","volume":"42","author":"Dohan","year":"1966","journal-title":"Acta Psychiatr Scand"},{"key":"ref211","first-page":"385","article-title":"Is schizophrenia rare if grain is rare?","volume":"19","author":"Dohan","year":"1984","journal-title":"Biol Psychiatry"},{"key":"ref212","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1600-0447.2005.00687.x","article-title":"The gluten connection: the association between schizophrenia and celiac disease","volume":"113","author":"Kalaydjian","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"ref213","first-page":"3","article-title":"Vitamin therapy in schizophrenia","volume":"45","author":"Hoffer","year":"2008","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"ref214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/CNM.1000105","article-title":"The effects of the ketogenic diet on psychiatric symptomatology, weight and metabolic dysfunction in schizophrenia patients","volume":"1","author":"Gilbert-Jaramillo","year":"2018","journal-title":"Clin Nut Metabolism"},{"key":"ref215","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1743-7075-6-10","article-title":"Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature","volume":"6","author":"Kraft","year":"2009","journal-title":"Nutr Metab (Lond)"},{"key":"ref216","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.schres.2017.01.053","article-title":"Ketogenic diet in the treatment of schizoaffective disorder: two case studies","volume":"189","author":"Palmer","year":"2017","journal-title":"Schizophr Res"},{"key":"ref217","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.schres.2019.03.019","article-title":"The ketogenic diet and remission of psychotic symptoms in schizophrenia: two case studies","volume":"208","author":"Palmer","year":"2019","journal-title":"Schizophr Res"},{"key":"ref218","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.schres.2004.03.024","article-title":"Atypical antipsychotics and glucose dysregulation: a systematic review","volume":"71","author":"Jin","year":"2004","journal-title":"Schizophr Res"},{"key":"ref219","doi-asserted-by":"publisher","first-page":"26375","DOI":"10.1038\/srep26375","article-title":"Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism","volume":"6","author":"Nagashima","year":"2016","journal-title":"Sci Rep"},{"key":"ref220","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1113\/JP282922","article-title":"Fasting or the short-term consumption of a ketogenic diet protects against antipsychotic-induced hyperglycaemia in mice","volume":"600","author":"Shamshoum","year":"2022","journal-title":"J Physiol"},{"key":"ref221","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00213-020-05467-2","article-title":"Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice","volume":"237","author":"Kraeuter","year":"2020","journal-title":"Psychopharmacology"},{"key":"ref222","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.psyneuen.2015.08.028","article-title":"Immobility in the forced swim test is adaptive and does not reflect depression","volume":"62","author":"Molendijk","year":"2015","journal-title":"Psychoneuroendocrinology"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1142682\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:00:25Z","timestamp":1681707625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1142682\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":222,"alternative-id":["10.3389\/fpsyt.2023.1142682"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1142682","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1142682"}}